Bampton PA - Search Results

1

Non-endoscopic screening for Barrett's oesophagus.

Bampton PA. Bampton PA. BMJ. 2010 Sep 10;341:c4667. doi: 10.1136/bmj.c4667. BMJ. 2010. PMID: 20833744 No abstract available.

2

Improving surveillance for Barrett's oesophagus.

Bampton PA, Schloithe A, Bull J, Fraser RJ, Padbury RT, Watson DI. Bampton PA, et al. BMJ. 2006 Jun 3;332(7553):1320-3. doi: 10.1136/bmj.332.7553.1320. BMJ. 2006. PMID: 16740562 Free PMC article.

3

Outcome of endoscopy surveillance for Barrett's oesophagus.

Bright T, Schloithe A, Bull JA, Fraser RJ, Bampton P, Watson DI. Bright T, et al. ANZ J Surg. 2009 Nov;79(11):812-6. doi: 10.1111/j.1445-2197.2009.05107.x. ANZ J Surg. 2009. PMID: 20078532

4

Surveillance for Barrett's oesophagus: if you do it, do it properly.

Ramnath G, Bampton P. Ramnath G, et al. Med J Aust. 2004 Feb 2;180(3):139-40. doi: 10.5694/j.1326-5377.2004.tb05840.x. Med J Aust. 2004. PMID: 14748680 No abstract available.

5

Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.

Collins MG, Teo E, Cole SR, Chan CY, McDonald SP, Russ GR, Young GP, Bampton PA, Coates PT. Collins MG, et al. Among authors: bampton pa. BMJ. 2012 Jul 25;345:e4657. doi: 10.1136/bmj.e4657. BMJ. 2012. PMID: 22833618 Free PMC article. Clinical Trial.

6

Achieving long-term compliance with colonoscopic surveillance guidelines for patients at increased risk of colorectal cancer in Australia.

Bampton PA, Sandford JJ, Young GP. Bampton PA, et al. Int J Clin Pract. 2007 Mar;61(3):510-3. doi: 10.1111/j.1742-1241.2006.01158.x. Int J Clin Pract. 2007. PMID: 17313621

7

Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia.

Bampton PA, Sandford JJ, Young GP. Bampton PA, et al. Med J Aust. 2002 Feb 18;176(4):155-7. doi: 10.5694/j.1326-5377.2002.tb04344.x. Med J Aust. 2002. PMID: 11913914

8

The National Bowel Cancer Screening Program--consequences for practice.

Bobridge A, Cole S, Schoeman M, Lewis H, Bampton P, Young G. Bobridge A, et al. Aust Fam Physician. 2013 Mar;42(3):141-5. Aust Fam Physician. 2013. PMID: 23529526 Free article.

9

Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.

Worthley DL, Smith A, Bampton PA, Cole SR, Young GP. Worthley DL, et al. Among authors: bampton pa. Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1079-83. doi: 10.1097/01.meg.0000231754.35340.fa. Eur J Gastroenterol Hepatol. 2006. PMID: 16957514

10

Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer.

Lindblad M, Bright T, Schloithe A, Mayne GC, Chen G, Bull J, Bampton PA, Fraser RJ, Gatenby PA, Gordon LG, Watson DI. Lindblad M, et al. Among authors: bampton pa. World J Surg. 2017 Apr;41(4):1023-1034. doi: 10.1007/s00268-016-3819-0. World J Surg. 2017. PMID: 27882416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page